Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium

Claudia I. Caldiz, Carolina D. Garciarena, Raúl A. Dulce, Leonardo P. Novaretto, Alejandra M. Yeves, Irene L. Ennis, Horacio E. Cingolani, Gladys Chiappe De Cingolani, Néstor G. Pérez

Research output: Contribution to journalArticle

Abstract

When the length of the myocardium is increased, a biphasic response to stretch occurs involving an initial rapid increase in force followed by a delayed slow increase called the slow force response (SFR). Confirming previous findings involving angiotensin II in the SFR, it was blunted by AT1 receptor blockade (losartan). The SFR was accompanied by an increase in reactive oxygen species (ROS) of ∼30% and in intracellular Na+ concentration ([Na+]i) of ∼2.5 mmol l-1 over basal detected by H2DCFDA and SBFI fluorescence, respectively. Abolition of ROS by 2-mercapto-propionyl-glycine (MPG) and EUK8 suppressed the increase in [Na+]i and the SFR, which were also blunted by Na+/H+ exchanger (NHE-1) inhibition (HOE642). NADPH oxidase inhibition (apocynin or DPI) or blockade of the ATP-sensitive mitochondrial potassium channels (5HD or glybenclamide) suppressed both the SFR and the increase in [Na+]i after stretch, suggesting that endogenous angiotensin II activated NADPH oxidase leading to ROS release by the ATP-sensitive mitochondrial potassium channels, which promoted NHE-1 activation. Supporting the notion of ROS-mediated NHE-1 activation, stretch increased the ERK1/2 and p90rsk kinases phosphorylation, effect that was cancelled by losartan. In agreement, the SFR was cancelled by inhibiting the ERK1/2 signalling pathway with PD98059. Angiotensin II at a dose that mimics the SFR (1 nmol l-1) induced an increase in ·O2- production of ∼30-40% detected by lucigenin in cardiac slices, an effect that was blunted by losartan, MPG, apocynin, 5HD and glybenclamide. Taken together the data suggest a pivotal role of mitochondrial ROS in the genesis of the SFR to stretch.

Original languageEnglish (US)
Pages (from-to)895-905
Number of pages11
JournalJournal of Physiology
Volume584
Issue number3
DOIs
StatePublished - Nov 1 2007
Externally publishedYes

Fingerprint

Felidae
Reactive Oxygen Species
Myocardium
Losartan
Angiotensin II
KATP Channels
Glyburide
NADPH Oxidase
Glycine
Sodium-Hydrogen Antiporter
MAP Kinase Signaling System
Phosphotransferases
Fluorescence
Phosphorylation
acetovanillone

ASJC Scopus subject areas

  • Physiology

Cite this

Caldiz, C. I., Garciarena, C. D., Dulce, R. A., Novaretto, L. P., Yeves, A. M., Ennis, I. L., ... Pérez, N. G. (2007). Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. Journal of Physiology, 584(3), 895-905. https://doi.org/10.1113/jphysiol.2007.141689

Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. / Caldiz, Claudia I.; Garciarena, Carolina D.; Dulce, Raúl A.; Novaretto, Leonardo P.; Yeves, Alejandra M.; Ennis, Irene L.; Cingolani, Horacio E.; Chiappe De Cingolani, Gladys; Pérez, Néstor G.

In: Journal of Physiology, Vol. 584, No. 3, 01.11.2007, p. 895-905.

Research output: Contribution to journalArticle

Caldiz, CI, Garciarena, CD, Dulce, RA, Novaretto, LP, Yeves, AM, Ennis, IL, Cingolani, HE, Chiappe De Cingolani, G & Pérez, NG 2007, 'Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium', Journal of Physiology, vol. 584, no. 3, pp. 895-905. https://doi.org/10.1113/jphysiol.2007.141689
Caldiz, Claudia I. ; Garciarena, Carolina D. ; Dulce, Raúl A. ; Novaretto, Leonardo P. ; Yeves, Alejandra M. ; Ennis, Irene L. ; Cingolani, Horacio E. ; Chiappe De Cingolani, Gladys ; Pérez, Néstor G. / Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. In: Journal of Physiology. 2007 ; Vol. 584, No. 3. pp. 895-905.
@article{2e25a87dc15a44f7826292ae61832361,
title = "Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium",
abstract = "When the length of the myocardium is increased, a biphasic response to stretch occurs involving an initial rapid increase in force followed by a delayed slow increase called the slow force response (SFR). Confirming previous findings involving angiotensin II in the SFR, it was blunted by AT1 receptor blockade (losartan). The SFR was accompanied by an increase in reactive oxygen species (ROS) of ∼30{\%} and in intracellular Na+ concentration ([Na+]i) of ∼2.5 mmol l-1 over basal detected by H2DCFDA and SBFI fluorescence, respectively. Abolition of ROS by 2-mercapto-propionyl-glycine (MPG) and EUK8 suppressed the increase in [Na+]i and the SFR, which were also blunted by Na+/H+ exchanger (NHE-1) inhibition (HOE642). NADPH oxidase inhibition (apocynin or DPI) or blockade of the ATP-sensitive mitochondrial potassium channels (5HD or glybenclamide) suppressed both the SFR and the increase in [Na+]i after stretch, suggesting that endogenous angiotensin II activated NADPH oxidase leading to ROS release by the ATP-sensitive mitochondrial potassium channels, which promoted NHE-1 activation. Supporting the notion of ROS-mediated NHE-1 activation, stretch increased the ERK1/2 and p90rsk kinases phosphorylation, effect that was cancelled by losartan. In agreement, the SFR was cancelled by inhibiting the ERK1/2 signalling pathway with PD98059. Angiotensin II at a dose that mimics the SFR (1 nmol l-1) induced an increase in ·O2- production of ∼30-40{\%} detected by lucigenin in cardiac slices, an effect that was blunted by losartan, MPG, apocynin, 5HD and glybenclamide. Taken together the data suggest a pivotal role of mitochondrial ROS in the genesis of the SFR to stretch.",
author = "Caldiz, {Claudia I.} and Garciarena, {Carolina D.} and Dulce, {Ra{\'u}l A.} and Novaretto, {Leonardo P.} and Yeves, {Alejandra M.} and Ennis, {Irene L.} and Cingolani, {Horacio E.} and {Chiappe De Cingolani}, Gladys and P{\'e}rez, {N{\'e}stor G.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1113/jphysiol.2007.141689",
language = "English (US)",
volume = "584",
pages = "895--905",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium

AU - Caldiz, Claudia I.

AU - Garciarena, Carolina D.

AU - Dulce, Raúl A.

AU - Novaretto, Leonardo P.

AU - Yeves, Alejandra M.

AU - Ennis, Irene L.

AU - Cingolani, Horacio E.

AU - Chiappe De Cingolani, Gladys

AU - Pérez, Néstor G.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - When the length of the myocardium is increased, a biphasic response to stretch occurs involving an initial rapid increase in force followed by a delayed slow increase called the slow force response (SFR). Confirming previous findings involving angiotensin II in the SFR, it was blunted by AT1 receptor blockade (losartan). The SFR was accompanied by an increase in reactive oxygen species (ROS) of ∼30% and in intracellular Na+ concentration ([Na+]i) of ∼2.5 mmol l-1 over basal detected by H2DCFDA and SBFI fluorescence, respectively. Abolition of ROS by 2-mercapto-propionyl-glycine (MPG) and EUK8 suppressed the increase in [Na+]i and the SFR, which were also blunted by Na+/H+ exchanger (NHE-1) inhibition (HOE642). NADPH oxidase inhibition (apocynin or DPI) or blockade of the ATP-sensitive mitochondrial potassium channels (5HD or glybenclamide) suppressed both the SFR and the increase in [Na+]i after stretch, suggesting that endogenous angiotensin II activated NADPH oxidase leading to ROS release by the ATP-sensitive mitochondrial potassium channels, which promoted NHE-1 activation. Supporting the notion of ROS-mediated NHE-1 activation, stretch increased the ERK1/2 and p90rsk kinases phosphorylation, effect that was cancelled by losartan. In agreement, the SFR was cancelled by inhibiting the ERK1/2 signalling pathway with PD98059. Angiotensin II at a dose that mimics the SFR (1 nmol l-1) induced an increase in ·O2- production of ∼30-40% detected by lucigenin in cardiac slices, an effect that was blunted by losartan, MPG, apocynin, 5HD and glybenclamide. Taken together the data suggest a pivotal role of mitochondrial ROS in the genesis of the SFR to stretch.

AB - When the length of the myocardium is increased, a biphasic response to stretch occurs involving an initial rapid increase in force followed by a delayed slow increase called the slow force response (SFR). Confirming previous findings involving angiotensin II in the SFR, it was blunted by AT1 receptor blockade (losartan). The SFR was accompanied by an increase in reactive oxygen species (ROS) of ∼30% and in intracellular Na+ concentration ([Na+]i) of ∼2.5 mmol l-1 over basal detected by H2DCFDA and SBFI fluorescence, respectively. Abolition of ROS by 2-mercapto-propionyl-glycine (MPG) and EUK8 suppressed the increase in [Na+]i and the SFR, which were also blunted by Na+/H+ exchanger (NHE-1) inhibition (HOE642). NADPH oxidase inhibition (apocynin or DPI) or blockade of the ATP-sensitive mitochondrial potassium channels (5HD or glybenclamide) suppressed both the SFR and the increase in [Na+]i after stretch, suggesting that endogenous angiotensin II activated NADPH oxidase leading to ROS release by the ATP-sensitive mitochondrial potassium channels, which promoted NHE-1 activation. Supporting the notion of ROS-mediated NHE-1 activation, stretch increased the ERK1/2 and p90rsk kinases phosphorylation, effect that was cancelled by losartan. In agreement, the SFR was cancelled by inhibiting the ERK1/2 signalling pathway with PD98059. Angiotensin II at a dose that mimics the SFR (1 nmol l-1) induced an increase in ·O2- production of ∼30-40% detected by lucigenin in cardiac slices, an effect that was blunted by losartan, MPG, apocynin, 5HD and glybenclamide. Taken together the data suggest a pivotal role of mitochondrial ROS in the genesis of the SFR to stretch.

UR - http://www.scopus.com/inward/record.url?scp=35648973667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648973667&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2007.141689

DO - 10.1113/jphysiol.2007.141689

M3 - Article

C2 - 17823205

AN - SCOPUS:35648973667

VL - 584

SP - 895

EP - 905

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 3

ER -